| Year |
Citation |
Score |
| 2023 |
Mázala DAG, Hindupur R, Moon YJ, Shaikh F, Gamu IH, Alladi D, Panci G, Weiss-Gayet M, Chazaud B, Partridge TA, Novak JS, Jaiswal JK. Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD. Cell Death Discovery. 9: 224. PMID 37402716 DOI: 10.1038/s41420-023-01503-0 |
0.441 |
|
| 2023 |
Mázala DAG, Hindupur R, Moon YJ, Shaikh F, Gamu IH, Alladi D, Panci G, Weiss-Gayet M, Chazaud B, Partridge TA, Novak JS, Jaiswal JK. Altered muscle niche contributes to myogenic deficit in the D2- model of severe DMD. Biorxiv : the Preprint Server For Biology. PMID 37034785 DOI: 10.1101/2023.03.27.534413 |
0.437 |
|
| 2021 |
Echigoya Y, Trieu N, Duddy W, Moulton HM, Yin H, Partridge TA, Hoffman EP, Kornegay JN, Rohret FA, Rogers CS, Yokota T. A Exon-52 Deleted Miniature Pig Model of Duchenne Muscular Dystrophy and Evaluation of Exon Skipping. International Journal of Molecular Sciences. 22. PMID 34884867 DOI: 10.3390/ijms222313065 |
0.437 |
|
| 2021 |
Benny Klimek ME, Vila MC, Edwards K, Boehler J, Novak J, Zhang A, Van der Mulen JH, Tatum K, Quinn J, Fiorillo A, Burki U, Straub V, Lu QL, Hathout Y, van Den Anker J, ... Partridge TA, et al. Effects of Chronic, Maximal Phosphorodiamidate Morpholino Oligomer (PMO) Dosing on Muscle Function and Dystrophin Restoration in a Mouse Model of Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases. PMID 34569970 DOI: 10.3233/JND-210701 |
0.403 |
|
| 2021 |
Novak JS, Spathis R, Dang UJ, Fiorillo AA, Hindupur R, Tully CB, Mázala DAG, Canessa E, Brown KJ, Partridge TA, Hathout Y, Nagaraju K. Interrogation of Dystrophin and Dystroglycan Complex Protein Turnover After Exon Skipping Therapy. Journal of Neuromuscular Diseases. PMID 34569969 DOI: 10.3233/JND-210696 |
0.436 |
|
| 2021 |
Partridge TA. Enhancing Interrogation of Skeletal Muscle Samples for Informative Quantitative Data. Journal of Neuromuscular Diseases. PMID 34511511 DOI: 10.3233/JND-210736 |
0.354 |
|
| 2021 |
Novak JS, Mázala DAG, Nearing M, Hindupur R, Uapinyoying P, Habib NF, Dickson T, Ioffe OB, Harris BT, Fidelia-Lambert MN, Rossi CT, Hill DA, Wagner KR, Hoffman EP, Partridge TA. Human muscle stem cells are refractory to aging. Aging Cell. e13411. PMID 34089289 DOI: 10.1111/acel.13411 |
0.449 |
|
| 2020 |
Uapinyoying P, Goecks J, Knoblach SM, Panchapakesan K, Bonnemann CG, Partridge TA, Jaiswal JK, Hoffman EP. A long-read RNA-seq approach to identify novel transcripts of very large genes. Genome Research. PMID 32660935 DOI: 10.1101/Gr.259903.119 |
0.359 |
|
| 2020 |
Mázala DA, Novak JS, Hogarth MW, Nearing M, Adusumalli P, Tully CB, Habib NF, Gordish-Dressman H, Chen YW, Jaiswal JK, Partridge TA. TGF-β-driven muscle degeneration and failed regeneration underlie disease onset in a DMD mouse model. Jci Insight. 5. PMID 32213706 DOI: 10.1172/Jci.Insight.135703 |
0.457 |
|
| 2020 |
Morgan J, Partridge T. Skeletal muscle in health and disease. Disease Models & Mechanisms. 13. PMID 32066552 DOI: 10.1242/Dmm.042192 |
0.543 |
|
| 2019 |
Hogarth MW, Defour A, Lazarski C, Gallardo E, Manera JD, Partridge TA, Nagaraju K, Jaiswal JK. Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B. Nature Communications. 10: 2430. PMID 31160583 DOI: 10.1038/S41467-019-10438-Z |
0.531 |
|
| 2019 |
Vila MC, Novak JS, Benny Klimek M, Li N, Morales M, Fritz AG, Edwards K, Boehler JF, Hogarth MW, Kinder TB, Zhang A, Mazala D, Fiorillo AA, Douglas B, Chen YW, ... ... Partridge TA, et al. Morpholino-induced exon skipping stimulates cell-mediated and humoral responses to dystrophin in mdx mice. The Journal of Pathology. PMID 30883742 DOI: 10.1002/Path.5263 |
0.382 |
|
| 2018 |
Lim KRQ, Echigoya Y, Nagata T, Kuraoka M, Kobayashi M, Aoki Y, Partridge T, Maruyama R, Takeda S, Yokota T. Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 30448197 DOI: 10.1016/J.Ymthe.2018.10.011 |
0.485 |
|
| 2018 |
Akpulat U, Wang H, Becker K, Contreras A, Partridge TA, Novak JS, Cirak S. Shorter Phosphorodiamidate Morpholino Splice-Switching Oligonucleotides May Increase Exon-Skipping Efficacy in DMD. Molecular Therapy. Nucleic Acids. 13: 534-542. PMID 30396145 DOI: 10.1016/J.Omtn.2018.10.002 |
0.507 |
|
| 2018 |
Nearing M, Novak J, Partridge T. Greater Colo-Rectal Activation Phenotype in Exercised mdx Mice. Plos Currents. 10. PMID 29862132 DOI: 10.1371/Currents.Md.230Ed3D6559B171E10279Fc16E9Ebef3 |
0.341 |
|
| 2018 |
Novak JS, Jaiswal JK, Partridge TA. The macrophage as a Trojan horse for antisense oligonucleotide delivery. Expert Opinion On Therapeutic Targets. PMID 29860876 DOI: 10.1080/14728222.2018.1482279 |
0.474 |
|
| 2018 |
Novak JS, Hogarth MW, Boehler JF, Nearing M, Vila MC, Heredia R, Fiorillo AA, Zhang A, Hathout Y, Hoffman EP, Jaiswal JK, Nagaraju K, Cirak S, Partridge TA. Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle. Nature Communications. 9: 208. PMID 29335405 DOI: 10.1038/S41467-017-02206-8 |
0.379 |
|
| 2017 |
Novak JS, Hogarth MW, Boehler JF, Nearing M, Vila MC, Heredia R, Fiorillo AA, Zhang A, Hathout Y, Hoffman EP, Jaiswal JK, Nagaraju K, Cirak S, Partridge TA. Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle. Nature Communications. 8: 941. PMID 29038471 DOI: 10.1038/S41467-017-00924-7 |
0.473 |
|
| 2016 |
Echigoya Y, Trieu N, Hosoki K, Duddy W, Partridge T, Hoffman E, Kornegay J, Rogers C, Yokota T. 623. Dystrophin Exon 52-Deleted Pigs as a New Animal Model of Duchenne Muscular Dystrophy: Its Characterization and Potential as a Tool for Developing Exon Skipping Therapy Molecular Therapy. 24. DOI: 10.1016/S1525-0016(16)33431-1 |
0.517 |
|
| 2016 |
Novak JS, Nearing M, Hogarth MW, Vila MC, Boehler JF, Hoffman EP, Nagaraju K, Cirak S, Partridge TA. 584. Myoblast Fusion Mediates Morpholino Entry and Exon Skipping In Dystrophic Muscle Molecular Therapy. 24: S232. DOI: 10.1016/S1525-0016(16)33392-5 |
0.572 |
|
| 2015 |
Vila MC, Klimek MB, Novak JS, Rayavarapu S, Uaesoontrachoon K, Boehler JF, Fiorillo AA, Hogarth MW, Zhang A, Shaughnessy C, Gordish-Dressman H, Burki U, Straub V, Lu QL, Partridge TA, et al. Elusive sources of variability of dystrophin rescue by exon skipping. Skeletal Muscle. 5: 44. PMID 26634117 DOI: 10.1186/S13395-015-0070-6 |
0.449 |
|
| 2015 |
Coley WD, Bogdanik L, Vila MC, Yu Q, van der Meulen JH, Rayavarapu S, Novak JS, Nearing M, Quinn JL, Saunders A, Dolan C, Andrews W, Lammert C, Austin A, Partridge TA, et al. Effect of genetic background on the dystrophic phenotype in mdx mice. Human Molecular Genetics. PMID 26566673 DOI: 10.1093/Hmg/Ddv460 |
0.442 |
|
| 2015 |
Fiorillo AA, Heier CR, Novak JS, Tully CB, Brown KJ, Uaesoontrachoon K, Vila MC, Ngheim PP, Bello L, Kornegay JN, Angelini C, Partridge TA, Nagaraju K, Hoffman EP. TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy. Cell Reports. 12: 1678-90. PMID 26321630 DOI: 10.1016/J.Celrep.2015.07.066 |
0.407 |
|
| 2015 |
Cohen TV, Many GM, Fleming BD, Gnocchi VF, Ghimbovschi S, Mosser DM, Hoffman EP, Partridge TA. Upregulated IL-1β in dysferlin-deficient muscle attenuates regeneration by blunting the response to pro-inflammatory macrophages. Skeletal Muscle. 5: 24. PMID 26251696 DOI: 10.1186/S13395-015-0048-4 |
0.483 |
|
| 2015 |
Duddy W, Duguez S, Johnston H, Cohen TV, Phadke A, Gordish-Dressman H, Nagaraju K, Gnocchi V, Low S, Partridge T. Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia. Skeletal Muscle. 5: 16. PMID 25987977 DOI: 10.1186/S13395-015-0041-Y |
0.534 |
|
| 2014 |
Partridge T. Could exon skipping help dystrophic boys to run, hop, and jump? Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1884-1886. PMID 25365985 DOI: 10.1038/Mt.2014.189 |
0.522 |
|
| 2014 |
Dadgar S, Wang Z, Johnston H, Kesari A, Nagaraju K, Chen YW, Hill DA, Partridge TA, Giri M, Freishtat RJ, Nazarian J, Xuan J, Wang Y, Hoffman EP. Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy. The Journal of Cell Biology. 207: 139-58. PMID 25313409 DOI: 10.1083/Jcb.201402079 |
0.5 |
|
| 2014 |
Hathout Y, Marathi RL, Rayavarapu S, Zhang A, Brown KJ, Seol H, Gordish-Dressman H, Cirak S, Bello L, Nagaraju K, Partridge T, Hoffman EP, Takeda S, Mah JK, Henricson E, et al. Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients. Human Molecular Genetics. 23: 6458-69. PMID 25027324 DOI: 10.1093/Hmg/Ddu366 |
0.385 |
|
| 2014 |
Bricceno KV, Martinez T, Leikina E, Duguez S, Partridge TA, Chernomordik LV, Fischbeck KH, Sumner CJ, Burnett BG. Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamics. Human Molecular Genetics. 23: 4745-57. PMID 24760765 DOI: 10.1093/Hmg/Ddu189 |
0.512 |
|
| 2014 |
Zhang Y, King OD, Rahimov F, Jones TI, Ward CW, Kerr JP, Liu N, Emerson CP, Kunkel LM, Partridge TA, Wagner KR. Human skeletal muscle xenograft as a new preclinical model for muscle disorders. Human Molecular Genetics. 23: 3180-8. PMID 24452336 DOI: 10.1093/Hmg/Ddu028 |
0.514 |
|
| 2013 |
Aoki Y, Nagata T, Yokota T, Nakamura A, Wood MJ, Partridge T, Takeda S. Highly efficient in vivo delivery of PMO into regenerating myotubes and rescue in laminin-α2 chain-null congenital muscular dystrophy mice. Human Molecular Genetics. 22: 4914-28. PMID 23882132 DOI: 10.1093/Hmg/Ddt341 |
0.513 |
|
| 2013 |
Partridge TA. The mdx mouse model as a surrogate for Duchenne muscular dystrophy Febs Journal. 280: 4177-4186. PMID 23551987 DOI: 10.1111/Febs.12267 |
0.387 |
|
| 2013 |
Cohen TV, Gnocchi VF, Cohen JE, Phadke A, Liu H, Ellis JA, Foisner R, Stewart CL, Zammit PS, Partridge TA. Defective skeletal muscle growth in lamin A/C-deficient mice is rescued by loss of Lap2α. Human Molecular Genetics. 22: 2852-69. PMID 23535822 DOI: 10.1093/Hmg/Ddt135 |
0.468 |
|
| 2013 |
Duguez S, Duddy W, Johnston H, Lainé J, Le Bihan MC, Brown KJ, Bigot A, Hathout Y, Butler-Browne G, Partridge T. Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion Cellular and Molecular Life Sciences. 70: 2159-2174. PMID 23344255 DOI: 10.1007/S00018-012-1248-2 |
0.389 |
|
| 2012 |
Lepper C, Low S, Partridge TA. The satellite cell builds its nest under Notch's guidance. Cell Stem Cell. 11: 443-4. PMID 23040471 DOI: 10.1016/J.Stem.2012.09.010 |
0.411 |
|
| 2012 |
Yokota T, Nakamura A, Nagata T, Saito T, Kobayashi M, Aoki Y, Echigoya Y, Partridge T, Hoffman EP, Takeda S. Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs Nucleic Acid Therapeutics. 22: 306-315. PMID 22888777 DOI: 10.1089/Nat.2012.0368 |
0.48 |
|
| 2012 |
Aoki Y, Yokota T, Nagata T, Nakamura A, Tanihata J, Saito T, Duguez SMR, Nagaraju K, Hoffman EP, Partridge T, Takeda S. Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery Proceedings of the National Academy of Sciences of the United States of America. 109: 13763-13768. PMID 22869723 DOI: 10.1073/Pnas.1204638109 |
0.495 |
|
| 2012 |
Cohen TV, Cohen JE, Partridge TA. Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response. Neuromuscular Disorders : Nmd. 22: 648-58. PMID 22560623 DOI: 10.1016/J.Nmd.2012.03.002 |
0.489 |
|
| 2011 |
Partridge TA. Impending therapies for Duchenne muscular dystrophy Current Opinion in Neurology. 24: 415-422. PMID 21892079 DOI: 10.1097/Wco.0B013E32834Aa3F1 |
0.482 |
|
| 2011 |
Lepper C, Partridge TA, Fan CM. An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration. Development (Cambridge, England). 138: 3639-46. PMID 21828092 DOI: 10.1242/Dev.067595 |
0.423 |
|
| 2011 |
Duddy WJ, Cohen T, Duguez S, Partridge TA. The isolated muscle fibre as a model of disuse atrophy: characterization using PhAct, a method to quantify f-actin. Experimental Cell Research. 317: 1979-93. PMID 21635888 DOI: 10.1016/J.Yexcr.2011.05.013 |
0.495 |
|
| 2011 |
Lu QL, Yokota T, Takeda S, Garcia L, Muntoni F, Partridge T. The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy Molecular Therapy. 19: 9-15. PMID 20978473 DOI: 10.1038/Mt.2010.219 |
0.352 |
|
| 2010 |
Guerron AD, Rawat R, Sali A, Spurney CF, Pistilli E, Cha HJ, Pandey GS, Gernapudi R, Francia D, Farajian V, Escolar DM, Bossi L, Becker M, Zerr P, de la Porte S, ... ... Partridge T, et al. Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy. Plos One. 5: e11220. PMID 20574530 DOI: 10.1371/Journal.Pone.0011220 |
0.464 |
|
| 2010 |
Partridge T. The potential of exon skipping for treatment for Duchenne muscular dystrophy Journal of Child Neurology. 25: 1165-1170. PMID 20519674 DOI: 10.1177/0883073810371130 |
0.365 |
|
| 2009 |
Amthor H, Otto A, Vulin A, Rochat A, Dumonceaux J, Garcia L, Mouisel E, Hourdé C, Macharia R, Friedrichs M, Relaix F, Zammit PS, Matsakas A, Patel K, Partridge T. Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity Proceedings of the National Academy of Sciences of the United States of America. 106: 7479-7484. PMID 19383783 DOI: 10.1073/pnas.0811129106 |
0.458 |
|
| 2009 |
Yokota T, Lu QL, Partridge T, Kobayashi M, Nakamura A, Takeda S, Hoffman E. Efficacy of systemic morpholino exon-skipping in duchenne dystrophy dogs Annals of Neurology. 65: 667-676. PMID 19288467 DOI: 10.1002/Ana.21627 |
0.41 |
|
| 2009 |
Spurney CF, Gordish-Dressman H, Guerron AD, Sali A, Pandey GS, Rawat R, Van Der Meulen JH, Cha HJ, Pistilli EE, Partridge TA, Hoffman EP, Nagaraju K. Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures. Muscle & Nerve. 39: 591-602. PMID 19260102 DOI: 10.1002/Mus.21211 |
0.306 |
|
| 2008 |
Partridge T. Denominator Problems in a Muscle Stem Cell Study? Cell. 135: 997-998. PMID 19070565 DOI: 10.1016/J.Cell.2008.11.033 |
0.528 |
|
| 2007 |
Ehrhardt J, Brimah K, Adkin C, Partridge T, Morgan J. Human muscle precursor cells give rise to functional satellite cells in vivo Neuromuscular Disorders. 17: 631-638. PMID 17588754 DOI: 10.1016/j.nmd.2007.04.009 |
0.45 |
|
| 2007 |
Alexakis C, Partridge T, Bou-Gharios G. Implication of the satellite cell in dystrophic muscle fibrosis: A self-perpetuating mechanism of collagen overproduction American Journal of Physiology - Cell Physiology. 293: C661-C669. PMID 17475662 DOI: 10.1152/ajpcell.00061.2007 |
0.383 |
|
| 2007 |
Amthor H, Macharia R, Navarrete R, Schuelke M, Brown SC, Otto A, Voit T, Muntoni F, Vrbóva G, Partridge T, Zammit P, Bunger L, Patel K. Lack of myostatin results in excessive muscle growth but impaired force generation Proceedings of the National Academy of Sciences of the United States of America. 104: 1835-1840. PMID 17267614 DOI: 10.1073/pnas.0604893104 |
0.441 |
|
| 2007 |
Collins CA, Zammit PS, Ruiz AP, Morgan JE, Partridge TA. A population of myogenic stem cells that survives skeletal muscle aging. Stem Cells (Dayton, Ohio). 25: 885-94. PMID 17218401 DOI: 10.1634/Stemcells.2006-0372 |
0.451 |
|
| 2006 |
Zammit PS, Partridge TA, Yablonka-Reuveni Z. The skeletal muscle satellite cell: the stem cell that came in from the cold. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 54: 1177-91. PMID 16899758 DOI: 10.1369/Jhc.6R6995.2006 |
0.466 |
|
| 2006 |
Nagata Y, Partridge TA, Matsuda R, Zammit PS. Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling. The Journal of Cell Biology. 174: 245-53. PMID 16847102 DOI: 10.1083/Jcb.200605028 |
0.454 |
|
| 2006 |
Yokota T, Lu QL, Morgan JE, Davies KE, Fisher R, Takeda S, Partridge TA. Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. Journal of Cell Science. 119: 2679-87. PMID 16757519 DOI: 10.1242/jcs.03000 |
0.454 |
|
| 2006 |
Zammit PS, Relaix F, Nagata Y, Ruiz AP, Collins CA, Partridge TA, Beauchamp JR. Pax7 and myogenic progression in skeletal muscle satellite cells. Journal of Cell Science. 119: 1824-32. PMID 16608873 DOI: 10.1242/jcs.02908 |
0.327 |
|
| 2006 |
Tam JL, Triantaphyllopoulos K, Todd H, Raguz S, de Wit T, Morgan JE, Partridge TA, Makrinou E, Grosveld F, Antoniou M. The human desmin locus: gene organization and LCR-mediated transcriptional control. Genomics. 87: 733-46. PMID 16545539 DOI: 10.1016/J.Ygeno.2006.01.009 |
0.429 |
|
| 2006 |
Alter J, Lou F, Rabinowitz A, Yin H, Rosenfeld J, Wilton SD, Partridge TA, Lu QL. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nature Medicine. 12: 175-7. PMID 16444267 DOI: 10.1038/nm1345 |
0.459 |
|
| 2006 |
Ashar J, Partridge T, Lu QL. 721. Antisense Oligonucleotide Therapy for Duchenne Muscular Dystrophy: From Cell Culture to Clinical Trial Molecular Therapy. 13. DOI: 10.1016/J.Ymthe.2006.08.800 |
0.521 |
|
| 2005 |
Collins CA, Partridge TA. Self-renewal of the adult skeletal muscle satellite cell. Cell Cycle (Georgetown, Tex.). 4: 1338-41. PMID 16177569 |
0.326 |
|
| 2005 |
Montarras D, Morgan J, Colins C, Relaix F, Zaffran S, Cumano A, Partridge T, Buckingham M. Developmental biology: Direct isolation of satellite cells for skeletal muscle regeneration Science. 309: 2064-2067. PMID 16141372 DOI: 10.1126/Science.1114758 |
0.447 |
|
| 2005 |
Collins CA, Olsen I, Zammit PS, Heslop L, Petrie A, Partridge TA, Morgan JE. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell. 122: 289-301. PMID 16051152 DOI: 10.1016/j.cell.2005.05.010 |
0.34 |
|
| 2005 |
Morrison J, Partridge T, Bou-Gharios G. Nude mutation influences limb skeletal muscle development Matrix Biology. 23: 535-542. PMID 15694130 DOI: 10.1016/j.matbio.2004.10.003 |
0.48 |
|
| 2005 |
Partridge T. Versatility and commitment in muscle Journal of Physiology. 562: 646. PMID 15611011 DOI: 10.1113/jphysiol.2004.080671 |
0.431 |
|
| 2005 |
Lu QL, Rabinowitz A, Chen YC, Yokota T, Yin H, Alter J, Jadoon A, Bou-Gharios G, Partridge T. Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. Proceedings of the National Academy of Sciences of the United States of America. 102: 198-203. PMID 15608067 DOI: 10.1073/pnas.0406700102 |
0.478 |
|
| 2004 |
Partridge T. Reenthronement of the muscle satellite cell Cell. 119: 447-448. PMID 15537532 DOI: 10.1016/j.cell.2004.10.022 |
0.372 |
|
| 2004 |
Zammit PS, Carvajal JJ, Golding JP, Morgan JE, Summerbell D, Zolnerciks J, Partridge TA, Rigby PW, Beauchamp JR. Myf5 expression in satellite cells and spindles in adult muscle is controlled by separate genetic elements. Developmental Biology. 273: 454-65. PMID 15328025 DOI: 10.1016/j.ydbio.2004.05.038 |
0.316 |
|
| 2004 |
Zammit PS, Golding JP, Nagata Y, Hudon V, Partridge TA, Beauchamp JR. Muscle satellite cells adopt divergent fates: a mechanism for self-renewal? The Journal of Cell Biology. 166: 347-57. PMID 15277541 DOI: 10.1083/jcb.200312007 |
0.329 |
|
| 2004 |
Cousins JC, Woodward KJ, Gross JG, Partridge TA, Morgan JE. Regeneration of skeletal muscle from transplanted immortalised myoblasts is oligoclonal. Journal of Cell Science. 117: 3259-69. PMID 15199096 DOI: 10.1242/jcs.01161 |
0.372 |
|
| 2004 |
Reimann J, Brimah K, Schröder R, Wernig A, Beauchamp JR, Partridge TA. Pax7 distribution in human skeletal muscle biopsies and myogenic tissue cultures. Cell and Tissue Research. 315: 233-42. PMID 14648195 DOI: 10.1007/s00441-003-0833-y |
0.344 |
|
| 2003 |
Lu QL, Mann CJ, Lou F, Bou-Gharios G, Morris GE, Xue SA, Fletcher S, Partridge TA, Wilton SD. Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Nature Medicine. 9: 1009-14. PMID 12847521 DOI: 10.1038/nm897 |
0.373 |
|
| 2003 |
Morgan JE, Partridge TA. Muscle satellite cells. The International Journal of Biochemistry & Cell Biology. 35: 1151-6. PMID 12757751 DOI: 10.1016/S1357-2725(03)00042-6 |
0.411 |
|
| 2003 |
Partridge TA. Stem cell route to neuromuscular therapies Muscle and Nerve. 27: 133-141. PMID 12548520 DOI: 10.1002/mus.10243 |
0.39 |
|
| 2002 |
Zammit PS, Heslop L, Hudon V, Rosenblatt JD, Tajbakhsh S, Buckingham ME, Beauchamp JR, Partridge TA. Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers. Experimental Cell Research. 281: 39-49. PMID 12441128 DOI: 10.1006/excr.2002.5653 |
0.325 |
|
| 2002 |
Goldring K, Partridge T, Watt D. Muscle stem cells. The Journal of Pathology. 197: 457-67. PMID 12115862 DOI: 10.1002/path.1157 |
0.436 |
|
| 2002 |
Morgan JE, Gross JG, Pagel CN, Beauchamp JR, Fassati A, Thrasher AJ, Di Santo JP, Fisher IB, Shiwen X, Abraham DJ, Partridge TA. Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site. The Journal of Cell Biology. 157: 693-702. PMID 12011114 DOI: 10.1083/jcb.200108047 |
0.339 |
|
| 1990 |
Morgan JE, Hoffman EP, Partridge TA. Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. The Journal of Cell Biology. 111: 2437-49. PMID 2277066 DOI: 10.1083/Jcb.111.6.2437 |
0.522 |
|
| Show low-probability matches. |